COST Action CA18218

Conducting national burden of disease studies in small countries in Europe: a feasible challenge?

Small countries usually face a number of challenges to conduct national burden of disease studies, amongst others due to the lack of specific expertise and resources or absence of adequate data. In a new Commentary published in Archives of Public Health, representatives of Europe’s small countries (Cyprus, Iceland, Luxembourg, Malta and Montenegro) discuss the unique challenges they face when engaging in such a study. They conclude that investing in sharing expert knowledge through the European Burden of Disease Network can facilitate the conduct of country specific BoD studies and the establishment of more accurate DALY estimates.

The publication can be accessed via https://archpublichealth.biomedcentral.com/articles/10.1186/s13690-021-00599-z.

About COST

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. COST Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. Read more via cost.eu.

Get in touch

COST logo

Funded by the European Union

Website by  woluweb mini